Claritin allergy relief

Claritin is a leading non-drowsy antihistamine brand used to treat symptoms of allergic rhinitis and common skin allergies. The brand's history is rooted in the development of loratadine, which was discovered in the late 1970s and launched as a prescription medication before eventually transitioning to over-the-counter status. Today, it stands as one of the most recognizable names in the pharmaceutical allergy category globally.

The manufacturing of Claritin products occurs across a global network of facilities, with major production sites located in the United States, Mexico, and various European countries. While the core formulations are consistent, regional packaging and distribution are handled by local entities under the supervision of the parent company's global supply chain.

Claritin is currently owned by Bayer AG, a German multinational pharmaceutical and life sciences company. Bayer acquired the brand as part of its purchase of the Merck & Co. consumer care business in 2014. Under Bayer's ownership, the Claritin brand has expanded its product line to include various formulations such as Liqui-Gels and RediTabs, solidifying its position in the international healthcare market.